Cargando…

Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study

Nausea and vomiting are common for runners during ultramarathons and often contribute to non-finishes. We aimed to determine the efficacy of ondansetron, a commonly used antiemetic, to treat nausea and vomiting in runners during an ultramarathon. Runners who had a previous history of frequent nausea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasternak, Andrew V., Fiore, David, Islas, Arthur, Toti, Sarah, Hoffman, Martin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001581/
https://www.ncbi.nlm.nih.gov/pubmed/33802399
http://dx.doi.org/10.3390/sports9030035
_version_ 1783671263681576960
author Pasternak, Andrew V.
Fiore, David
Islas, Arthur
Toti, Sarah
Hoffman, Martin D.
author_facet Pasternak, Andrew V.
Fiore, David
Islas, Arthur
Toti, Sarah
Hoffman, Martin D.
author_sort Pasternak, Andrew V.
collection PubMed
description Nausea and vomiting are common for runners during ultramarathons and often contribute to non-finishes. We aimed to determine the efficacy of ondansetron, a commonly used antiemetic, to treat nausea and vomiting in runners during an ultramarathon. Runners who had a previous history of frequent nausea or vomiting during races and entered in 160, 80, and 55 km ultramarathons in 2018 and 2019 were randomized in a double-blind fashion to 4 mg ondansetron or placebo capsules to use if they developed nausea or vomiting during the race with the ability to take three additional doses. Study participants completed a post-race online survey to assess medication use and efficacy. Of 62 study participants, 31 took either ondansetron (20) or placebo (11). In this small study, there were no group differences in those reporting any improvement in nausea and vomiting (p = 0.26) or in the amount of improvement (p = 0.15). We found no evidence that ondansetron capsules improve nausea and vomiting during ultramarathons.
format Online
Article
Text
id pubmed-8001581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80015812021-03-28 Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study Pasternak, Andrew V. Fiore, David Islas, Arthur Toti, Sarah Hoffman, Martin D. Sports (Basel) Article Nausea and vomiting are common for runners during ultramarathons and often contribute to non-finishes. We aimed to determine the efficacy of ondansetron, a commonly used antiemetic, to treat nausea and vomiting in runners during an ultramarathon. Runners who had a previous history of frequent nausea or vomiting during races and entered in 160, 80, and 55 km ultramarathons in 2018 and 2019 were randomized in a double-blind fashion to 4 mg ondansetron or placebo capsules to use if they developed nausea or vomiting during the race with the ability to take three additional doses. Study participants completed a post-race online survey to assess medication use and efficacy. Of 62 study participants, 31 took either ondansetron (20) or placebo (11). In this small study, there were no group differences in those reporting any improvement in nausea and vomiting (p = 0.26) or in the amount of improvement (p = 0.15). We found no evidence that ondansetron capsules improve nausea and vomiting during ultramarathons. MDPI 2021-03-03 /pmc/articles/PMC8001581/ /pubmed/33802399 http://dx.doi.org/10.3390/sports9030035 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Pasternak, Andrew V.
Fiore, David
Islas, Arthur
Toti, Sarah
Hoffman, Martin D.
Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title_full Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title_fullStr Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title_full_unstemmed Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title_short Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
title_sort treatment with oral ondansetron for ultramarathon-associated nausea: the too fun study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001581/
https://www.ncbi.nlm.nih.gov/pubmed/33802399
http://dx.doi.org/10.3390/sports9030035
work_keys_str_mv AT pasternakandrewv treatmentwithoralondansetronforultramarathonassociatednauseathetoofunstudy
AT fioredavid treatmentwithoralondansetronforultramarathonassociatednauseathetoofunstudy
AT islasarthur treatmentwithoralondansetronforultramarathonassociatednauseathetoofunstudy
AT totisarah treatmentwithoralondansetronforultramarathonassociatednauseathetoofunstudy
AT hoffmanmartind treatmentwithoralondansetronforultramarathonassociatednauseathetoofunstudy